Most CROs focus on executing protocols exactly as written.
At Vedic Lifesciences, we start one step earlier by designing protocols intelligently.

Our approach is simple: simplify clinical studies without diluting scientific rigor, so sponsors can move faster, spend smarter, and generate meaningful insights earlier in the development journey. For us, flexibility is not a workaround or a compromise; it is a core design principle.

How Our Flexibility Creates Real Value

Lean Protocols

We remove non-essential endpoints and redundant assessments, ensuring studies remain focused on decision-critical outcomes, rather than excessive data collection that adds cost without clarity.

Fewer, Smarter Visits

Visit schedules are thoughtfully optimized to reduce patient burden while preserving data quality. This improves recruitment and retention and directly lowers operational cost.

Optional Exploratory Science

Exploratory biomarkers and sub-studies are structured as optional arms, allowing scientific depth to be added only when early signals justify expansion, without putting the core study at risk.

Virtual & Hybrid Follow-ups

Wherever feasible, non-essential follow-ups are transitioned to telephonic, video, or ePRO-based formats. This improves patient convenience while maintaining study integrity.

Right-Sized Samples

We typically design studies with 80% statistical power and realistic effect-size assumptions, helping sponsors avoid unnecessary over-enrollment and budget inflation.

Adaptive & Bayesian Thinking

Our philosophy is to start small, assess early, and scale only when data supports it. This adaptive mindset reduces risk while preserving flexibility for future expansion.

Smart Site Strategy

We prioritize academic hospitals and appropriate general practitioners over high-cost private sites—maintaining data quality while improving cost efficiency.

Proof from Vedic Experience

Nutraceutical Clinical Efficacy Study (India)

Vedic Lifesciences redesigned an over-complex sponsor protocol by:

• Reducing visit frequency by approximately 30%,

• Shifting exploratory biomarkers to an optional sub-cohort, and

• Optimizing sample size without compromising statistical validity.

Outcome:
Faster recruitment, improved compliance, and meaningful efficacy signals—delivered within a controlled budget and enabling the sponsor to confidently plan the next development phase.

Where We Excel

Vedic Lifesciences is purpose-built for borderline and emerging healthcare innovations, including nutraceuticals, devices, cosmeceuticals, and middle-of-the-pyramid solutions—areas where rigid CRO models often fail to deliver value.

The Vedic Promise

Design lean. Execute smart. Scale only when justified.

Vedic Lifesciences - A Flexible CRO for Real-World Healthcare Innovation